Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Genet Mol Res ; 15(1)2016 Mar 18.
Article in English | MEDLINE | ID: mdl-27050952

ABSTRACT

Chronic inflammation develops in the retinal microvasculature under sustained hyperglycemia and is implicated in the pathogenesis of diabetic retinopathy. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 have been reported to promote pro-inflammatory cytokines, which are involved in the pathogenesis of proliferative diabetic retinopathy (PDR). It is therefore possible that the TWEAK/Fn14 pathway can play a regulatory role in PDR. In the present study, we examined the expression of TWEAK and Fn14 in vitreous fluid from PDR patients. To confirm the correlation between the TWEAK expression and clinical pathological characteristics of PDR, we investigated the regulatory role of the TWEAK/Fn14 pathway in cell proliferation and collagen synthesis in retinal ARPE-19 cells. The results demonstrated that vitreous fluid from patients with PDR had higher levels of TWEAK and Fn14 than that from T2DM patients without PDR, thus suggesting an important regulatory role of TWEAK/Fn14 signaling in the pathogenesis of PDR. Furthermore, overexpression of TWEAK in ARPE-19 cells also promoted proliferation of and collagen synthesis in these retinal cells. It is possible that TWEAK/Fn14 upregulation in PDR may contribute to PDR progression by promoting the proliferation or fibrosis of retinal cells.


Subject(s)
Collagen/metabolism , Diabetic Retinopathy/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Retina/metabolism , Tumor Necrosis Factors/metabolism , Apoptosis/genetics , Apoptosis/physiology , Cell Line , Cell Proliferation/physiology , Cytokine TWEAK , Diabetes Mellitus, Type 2/metabolism , Diabetic Retinopathy/genetics , Female , Humans , Male , Middle Aged , Receptors, Tumor Necrosis Factor/genetics , Retina/pathology , TWEAK Receptor , Tumor Necrosis Factors/genetics , Vitreous Body/metabolism
2.
Brachytherapy ; 14(3): 316-21, 2015.
Article in English | MEDLINE | ID: mdl-25454576

ABSTRACT

PURPOSE: To determine whether computed tomography/magnetic resonance imaging-based day 0 (d0) dosimetry is a meaningful predictor of day 21 (d21) dosimetry in low-dose-rate brachytherapy for localized prostate cancer. METHODS AND MATERIALS: The study population consisted of 277 men with localized (T1-2 N0 M0), low-/intermediate-risk prostate cancer treated with low-dose-rate brachytherapy. Computed tomography/magnetic resonance imaging fusion was used for postimplant dosimetry at d0 and d21. Logistic regression was used to construct receiver operating characteristic curves for achieving each constraint at d21, based on d0 D90 and V100, and Youden's index was used to evaluate cutpoints. Freedom from biochemical failure (FBCF) was estimated with the Kaplan-Meier method. RESULTS: The median d0 D90 increased from 133 to 150 Gy at d21, and median d0 V100 increased from 87% to 91%. For achieving the D90 constraint at d21, the optimal cut-point for d0 D90 was 135 Gy, with 84% of these patients maintaining a d21 D90 > 145 Gy. For achieving the D90 constraint at d21, the optimal cut-point for d0 V100 was 87%, with 83% of these patients maintained a d21 V100 > 90%. There was no improvement in FBCF in patients with a d0 D90 > 135 Gy or D90 > 145 Gy. Similarly, there was no improvement in FBCF in patients with a d0 V100 > 87% or V100 > 90%. CONCLUSIONS: Meeting dosimetric constraints on d0 does not obviate d21 dosimetric analysis. Constraints used for dose prescriptions on d0 are not the ideal predictors of d21 dosimetry.


Subject(s)
Brachytherapy/methods , Prostatic Neoplasms/radiotherapy , Quality Assurance, Health Care , Radiometry/standards , Adult , Aged , Aged, 80 and over , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/pathology , Radiotherapy Dosage , Tomography, X-Ray Computed
3.
Genet Mol Res ; 12(3): 2771-8, 2013 Aug 02.
Article in English | MEDLINE | ID: mdl-23979902

ABSTRACT

Patterning of the limb anterior-posterior axes depends on several signals that derive from the three signaling centers of the limb bud. These signals interact to constitute a complex and ordered network that critically contributes to the development of limb buds. Preaxial polydactyly in mouse is predominantly caused by ectopic expression of the zone of polarizing activity or Sonic hedgehog in the anterior region of the limb bud. In this study, we describe an N-ethyl-N-nitrosourea-induced polydactylous mouse (Alx4m1Yzcm) with an extra digit on the anterior aspect of one or two hinddigits. The mutation was mapped to chromosome 2, between markers D2Mit45 and D2Mit184. The Alx4 gene was identified as a potential candidate gene in this location. Sequence analysis of the Alx4 gene for polydactylous heterozygotes revealed an A/T transversion mutation that resulted in substitution of a lysine codon with a stop (nonsense) codon at position 145. Alx4m1Yzcm homozygous mice exhibited multiple abnormalities, including extensive preaxial polydactyly of all four limbs (up to seven digits) and the formation of omphalocele.


Subject(s)
Codon, Nonsense , Hernia, Umbilical/genetics , Homeodomain Proteins/genetics , Polydactyly/genetics , Animals , Chromosomes, Mammalian/genetics , Ethylnitrosourea/toxicity , Genetic Loci , Heterozygote , Mice , Mice, Inbred C57BL , Mutagenesis , Teratogenesis/genetics
SELECTION OF CITATIONS
SEARCH DETAIL